Monoclonal Antibody (mAb) Characterization: Purity, Charge Heterogeneity and Glycan Analysis on a Single Platform Technology
The comprehensive characterization of protein therapeutics is essential for the biopharmaceutical industry and the NIST Monoclonal Antibody (NISTmAb). Reference Material 8671 has been developed as a test molecule for therapeutic protein characterization.
High quality CE-SDS purity, charge heterogeneity (CZE & cIEF) and N-glycan profiles of therapeutic proteins must be generated rapidly and accurately in order to properly characterize any biopharmaceutical. In this webcast, we will show data from analysis of the NISTmAb reference material to demonstrate how core biopharmaceutical characterization applications, including CE-SDS, CZE, cIEF, and N-glycan analysis, can be carried out on a single analytical platform—with speed, sensitivity, and the ability to quantitate.
Fill out the form to watch the webinar on-demand.
Esme Candish Ph.D.,
CESI Application Scientist, SCIEX
Can’t make this event? Check out the events calendar to see other upcoming events that may be of interest.